Targeting AMPK in Fat Cells to Fight Obesity and Breast Cancer
Author Information
Author(s): Jean Grisouard, Kaethi Dembinski, Doris Mayer, Ulrich Keller, Beat Müller, Mirjam Christ-Crain
Primary Institution: University Hospital Basel
Hypothesis
Can activating AMPK in adipocytes help reduce insulin resistance and breast cancer cell growth?
Conclusion
Activating AMPK and using metformin can improve the balance of adipokines, potentially reducing insulin resistance and breast cancer progression.
Supporting Evidence
- Conditioned media from adipocytes increased breast cancer cell proliferation.
- Metformin reduced LPS-induced IL-6 mRNA expression.
- Silencing AMPKalpha1 enhanced LPS-induced IL-6 and IL-8 mRNA expression.
Takeaway
This study shows that fat cells can affect breast cancer growth, and using certain drugs can help balance the substances they produce, which might help fight cancer.
Methodology
Human preadipocytes were differentiated into adipocytes and treated with LPS and metformin, followed by analysis of mRNA expression and breast cancer cell proliferation.
Potential Biases
Potential biases due to the small cohort and variability in adipose tissue responses.
Limitations
The small sample size and lack of gender-specific analysis limit the conclusions that can be drawn.
Participant Demographics
Obese donors (BMI > 30 kg/m2, mean age 47 years), both males and females.
Statistical Information
P-Value
p < 0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website